Skip to main content

Peer Review reports

From: Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma

Original Submission
17 Feb 2014 Submitted Original manuscript
18 Feb 2014 Author responded Author comments - Benjamin Haaland
Resubmission - Version 2
18 Feb 2014 Submitted Manuscript version 2
18 Feb 2014 Author responded Author comments - Benjamin Haaland
Resubmission - Version 3
18 Feb 2014 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
19 Feb 2014 Author responded Author comments - Benjamin Haaland
Resubmission - Version 5
19 Feb 2014 Submitted Manuscript version 5
16 Apr 2014 Reviewed Reviewer Report - Joaquim Bellmunt
20 May 2014 Reviewed Reviewer Report - Giuseppe di Lorenzo
25 May 2014 Reviewed Reviewer Report - Guru Sonpavde
23 Jun 2014 Author responded Author comments - Benjamin Haaland
Resubmission - Version 6
23 Jun 2014 Submitted Manuscript version 6
23 Jun 2014 Author responded Author comments - Benjamin Haaland
Resubmission - Version 7
23 Jun 2014 Submitted Manuscript version 7
23 Jun 2014 Author responded Author comments - Benjamin Haaland
Resubmission - Version 8
23 Jun 2014 Submitted Manuscript version 8
7 Jul 2014 Reviewed Reviewer Report - Guru Sonpavde
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
22 Jul 2014 Editorially accepted
15 Aug 2014 Article published 10.1186/1471-2407-14-592

You can find further information about peer review here.

Back to article page